{"entity":{"type":"insider","cik":"0001343266","url":"/insider/0001343266","json_url":"/insider/0001343266.json","name":"Pascoe Richard W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":17,"first":"2010-01-05","last":"2023-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Pascoe Richard W","source":"filing","n_filings":17,"first_seen":"2010-01-05","last_seen":"2023-03-13"}],"transactions":[{"id":8080636,"accession":"0001437749-23-006274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-006274","line_url":"/filing/0001437749-23-006274#line-1","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.1978,"price_display":"4.20","price_state":"stated","total_value":41978.0,"total_display":"41,978.00","total_whole":"41,978","shares_owned_after":29973.0,"shares_owned_after_display":"29,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-13","scope":"insider"},{"id":8127899,"accession":"0001437749-23-001059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-001059","line_url":"/filing/0001437749-23-001059#line-1","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":5.4399,"price_display":"5.44","price_state":"stated","total_value":51679.05,"total_display":"51,679.05","total_whole":"51,679","shares_owned_after":19973.0,"shares_owned_after_display":"19,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-13","scope":"insider"},{"id":6273678,"accession":"0001437749-22-012933","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-22-012933","line_url":"/filing/0001437749-22-012933","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.921518,"price_display":"4.92","price_state":"stated","total_value":24607.59,"total_display":"24,607.59","total_whole":"24,608","shares_owned_after":6252.0,"shares_owned_after_display":"6,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-18","scope":"insider","n_lines":7},{"id":4355128,"accession":"0001437749-21-027582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-027582","line_url":"/filing/0001437749-21-027582#line-1","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":7.8814,"price_display":"7.88","price_state":"stated","total_value":11822.1,"total_display":"11,822.10","total_whole":"11,822","shares_owned_after":3285.0,"shares_owned_after_display":"3,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-11-30","scope":"insider"},{"id":4331104,"accession":"0001209191-21-023623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023623","line_url":"/filing/0001209191-21-023623#line-1","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"Histogen Inc.","issuer_ticker":"HSTO","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President, CEO & Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":22800.0,"total_display":"22,800.00","total_whole":"22,800","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-03-30","scope":"insider"},{"id":2226032,"accession":"0001209191-20-061926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-061926","line_url":"/filing/0001209191-20-061926#line-1","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"Histogen Inc.","issuer_ticker":"HSTO","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President, CEO & Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & Director","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.2394,"price_display":"1.24","price_state":"stated","total_value":12394.0,"total_display":"12,394.00","total_whole":"12,394","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider"},{"id":2313151,"accession":"0001437749-20-018279","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-20-018279","line_url":"/filing/0001437749-20-018279","is_derivative":false,"issuer_cik":"0001343266","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001343266","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.63518,"price_display":"0.64","price_state":"stated","total_value":6351.8,"total_display":"6,351.80","total_whole":"6,352","shares_owned_after":25773.0,"shares_owned_after_display":"25,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider","n_lines":3},{"id":6893094,"accession":"0001017491-14-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001017491-14-000120","line_url":"/filing/0001017491-14-000120#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0217,"price_display":"1.02","price_state":"stated","total_value":10217.0,"total_display":"10,217.00","total_whole":"10,217","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-22","scope":"insider"},{"id":6569672,"accession":"0001017491-14-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001017491-14-000095","line_url":"/filing/0001017491-14-000095#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":18120.0,"total_display":"18,120.00","total_whole":"18,120","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-22","filed_date":"2014-10-24","scope":"insider"},{"id":4284034,"accession":"0001181431-13-030749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-030749","line_url":"/filing/0001181431-13-030749#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":99750.0,"total_display":"99,750.00","total_whole":"99,750","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-23","filed_date":"2013-05-24","scope":"insider"},{"id":2519210,"accession":"0001209191-12-000919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-000919","line_url":"/filing/0001209191-12-000919#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18750.0,"shares_display":"18,750","price_per_share":0.477,"price_display":"0.48","price_state":"stated","total_value":8943.75,"total_display":"8,943.75","total_whole":"8,944","shares_owned_after":230726.0,"shares_owned_after_display":"230,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":8988564,"accession":"0001209191-11-034177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-034177","line_url":"/filing/0001209191-11-034177#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11100.0,"shares_display":"11,100","price_per_share":2.2471,"price_display":"2.25","price_state":"stated","total_value":24942.81,"total_display":"24,942.81","total_whole":"24,943","shares_owned_after":207809.0,"shares_owned_after_display":"207,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-10","filed_date":"2011-06-13","scope":"insider"},{"id":7368728,"accession":"0001209191-10-058428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-058428","line_url":"/filing/0001209191-10-058428#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13781.0,"shares_display":"13,781","price_per_share":2.6832,"price_display":"2.68","price_state":"stated","total_value":36977.1792,"total_display":"36,977.18","total_whole":"36,977","shares_owned_after":71709.0,"shares_owned_after_display":"71,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"},{"id":7654419,"accession":"0001209191-10-018090","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-10-018090","line_url":"/filing/0001209191-10-018090","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104510.0,"shares_display":"104,510","price_per_share":5.987149765572672,"price_display":"5.99","price_state":"stated","total_value":625717.022,"total_display":"625,717.02","total_whole":"625,717","shares_owned_after":39190.0,"shares_owned_after_display":"39,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-18","filed_date":"2010-03-19","scope":"insider","n_lines":6},{"id":7716261,"accession":"0001209191-10-014263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-014263","line_url":"/filing/0001209191-10-014263#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":4.0131,"price_display":"4.01","price_state":"stated","total_value":160524.0,"total_display":"160,524.00","total_whole":"160,524","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-03","scope":"insider"},{"id":7689992,"accession":"0001209191-10-007983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-007983","line_url":"/filing/0001209191-10-007983#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62000.0,"shares_display":"62,000","price_per_share":3.0258,"price_display":"3.03","price_state":"stated","total_value":187599.6,"total_display":"187,599.60","total_whole":"187,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-05","filed_date":"2010-02-09","scope":"insider"},{"id":7471040,"accession":"0001209191-10-001303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-001303","line_url":"/filing/0001209191-10-001303#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001343266","owner_name":"Pascoe Richard W","owner_display_name":"Pascoe Richard W","owner_url":"/insider/0001343266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":1.0683,"price_display":"1.07","price_state":"stated","total_value":8546.4,"total_display":"8,546.40","total_whole":"8,546","shares_owned_after":52000.0,"shares_owned_after_display":"52,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2020-08-18","last_seen":"2023-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001383701","name":"Histogen Inc.","url":"/issuer/0001383701","role":"Director, Officer (President, CEO & Director)","n_filings":2,"first_seen":"2020-12-07","last_seen":"2021-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001017491","name":"APRICUS BIOSCIENCES, INC.","url":"/issuer/0001017491","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2013-05-24","last_seen":"2014-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Director, Officer (President and CEO)","n_filings":7,"first_seen":"2010-01-05","last_seen":"2012-01-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001343266","retrieved_at":"2026-08-22T22:17:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}